<DOC>
	<DOCNO>NCT00003063</DOCNO>
	<brief_summary>RATIONALE : Biological therapy use different way stimulate immune system stop cancer cell grow . Combining chemotherapy biological therapy may kill tumor cell . PURPOSE : Randomized phase III trial compare effectiveness treatment use levamisole treatment use interferon alfa combination chemotherapy consist fluorouracil leucovorin patient stage II stage III colorectal cancer .</brief_summary>
	<brief_title>Biological Therapy With Combination Chemotherapy Patients With Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Assess efficacy addition levamisole alfa interferon fluorouracil leucovorin calcium ( folinic acid ) adjuvant treatment intraperitoneal colorectal cancer . OUTLINE : This three arm study . Patients randomize receive either levamisole , alfa interferon , treatment . - Arm I : Patients receive levamisole PO 3 day every 2 week 6 month surgery . Fluorouracil IV bolus leucovorin calcium ( folinic acid ) IV 1 hour administer day 1-5 every 4 week 6 cycle surgery . - Arm II : Patients receive alfa interferon-2a SC 3 alternate day week surgery 6 month surgery . Fluorouracil IV bolus folinic acid IV 1 hour administer day 1-5 every 4 week 6 cycle surgery . - Arm III : Patients undergo surgery follow fluorouracil IV bolus folinic acid IV 1 hour day 1-5 every 4 week 6 cycle . Patients follow every 3 month 2 year , every 6 month . PROJECTED ACCRUAL : 350 patient per arm accrue total 1,050 patient .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Levamisole</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm stage T3T4 N0 T1T4 N13 colorectal cancer No evidence residual disease surgery Tumor locate peritoneal reflection No distant metastases PATIENT CHARACTERISTICS : Age : 75 Performance status : WHO 01 Life expectancy : Not specify Hematopoietic : WBC least 3500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 2.0 mg/dL SGPT le 2 time upper limit normal Renal : Creatinine great 2.0 mg/dL Cardiovascular : No serious cardiac ischemia Other : Adequate metabolic function No prior neoplasm No prior/concurrent illness No insulindependent diabetes PRIOR CONCURRENT THERAPY : Biologic therapy No prior immunotherapy current cancer Chemotherapy No prior chemotherapy current cancer Endocrine therapy Not specify Radiotherapy No prior radiotherapy current cancer Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2005</verification_date>
	<keyword>stage II colon cancer</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage II rectal cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
</DOC>